Pieris Pharmaceuticals, Inc.   (NASDAQ:PIRS)

1.99    $0.00   0.00%
At close   Wednesday, Jul 06 04:00 PM

Pieris Pharmaceuticals, Inc. Chart

PIRS Stock Price Today

Pieris Pharmaceuticals, Inc. (PIRS) stock rallied over 0.00% intraday to trade at $1.99 a share on NASDAQ. The stock opened with a gain of 0.51% at $1.99 and touched an intraday high of $, declining 100.00% against the last close of $1.98. The stock went to a low of $ during the session.

Stock Snapshot

1.98
Prev. Close
1.99
Open
137.91M
Market Cap
73.71M
Number of Shares

day Low

Day High
1.99
-
P/E ratio
1.63%
Free Float in %
-0.68
EPS (TTM)
0.73
Book Value per Share
1.45
Cash Flow per Share
-
Volume

Contact Details

255 State Street
9th Floor
Boston, MA 02109
United States
https://www.pieris.com
857 246 8998

Company Information

Employees114
Beta1.09
Sales or Revenue26.80M
5Y Sales Change40.10%
Fiscal Year Ends2021-12-30
SectorHealthcare
IndustryBiotechnology

About Company

Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate that is in Phase II clinical trial targeting IL-4Ra for the treatment of asthma and other inflammatory diseases; PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis; and immune-oncology program comprises Cinrebafusp alfa, a 4-1BB/ HER2 bispecific for the treatment of HER2-high and HER2-low expressing gastric cancers. The company also develops PRS-344/S095012, a bispecific anticalin-antibody fusion protein targeting 4- 1BB and PD-L1 for immuno-oncology diseases that is in phase 1 clinical trial; and PRS-352, a preclinical-stage program addressing undisclosed targets for immuno-oncology diseases. It has a license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier, AstraZeneca AB, and Seagen Inc.; and license agreements with Technical University of Munich, Enumeral Biomedical Holdings, Inc., and Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. The company also has a clinical trial collaboration and supply agreement with Eli Lilly and Company. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts.

Frequently Asked Questions

What is the current Pieris Pharmaceuticals, Inc. (PIRS) stock price?

Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) stock price is $1.99 as of the last check on Wednesday, Jul 06. During the trading session, PIRS stock reached the peak price of $ while $ was the lowest point it dropped to.

PIRS's industry and sector of operation?

The NASDAQ listed PIRS is part of Biotechnology industry that operates in the broader Healthcare sector. Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs.

What is the PIRS stock price today?

PIRS stock traded closed the last session at $1.99, which is $0.00 or 0.00% higher than its previous close of $1.98. PIRS's current trading price is -67.64% lower than its 52-week high of $6.15 where as its distance from 52-week low of $1.54 is 29.22%.

How many employees does PIRS have?

Number of PIRS employees currently stands at 114. PIRS operates from 255 State Street
9th Floor
Boston, MA 02109
United States.

Link for PIRS official website?


How do I contact PIRS?

PIRS could be contacted at 255 State Street
9th Floor
Boston, MA 02109
United States, or at phone # 857 246 8998 and can also be accessed through its website: https://www.pieris.com

How many shares of PIRS are traded daily?

PIRS stock volume for the day was - shares while in the previous session number of PIRS shares traded was . The average number of PIRS shares traded daily for last 3 months was 392450.

How much did PIRS change today?

The percentage change in PIRS stock occurred in the recent session was 0.00% while the dollar amount for the price change in PIRS stock was $0.00.

What price range PIRS stock been trading in?

In the recent session, the day high for PIRS stock was $ while the low for PIRS stock touched on the day was $.

What is the market cap of PIRS currently?

The market value of PIRS currently stands at $137.91M with its latest stock price at $1.99 and 73.71M of its shares outstanding.